Report No. 31/2026 Management Board’s Assessment of the List of Questions Received from the European Medicines Agency and Timeline for Further Activities in the BCX-CM-J Registration Process Przekaż swoją opinię na temat programu BizChat

_MACHINE TRANSLATION_ The Management Board of Bioceltix S.A. with its registered office in Wrocław (the “Issuer” or the “Company”), with reference to ESPI Current Report No. 28/2026 dated 16 July 2026 regarding the receipt from the European Medicines Agency (“EMA”) of a list of questions as part of the process of seeking a positive recommendation […]